Kerala HC calls for Centre's intervention on exorbitantly priced patented medicines

The Kerala high court has determined that the Centre is authorized to invoke the Patents Act to produce medicines. This ruling emerged from a case involving the costly cancer drug Ribociclib, which a patient requested, though the patient died before the conclusion of the case. The court underscored the importance of providing affordable medication, stressing that government intervention is necessary to enable access to critical treatments.